Human papillomavirus, current vaccines, and cervical cancer prevention

JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

Volumn 38, Issue 1, 2009, Pages 69-80

  Teitelman, Anne M ^a   Stringer, Marilyn ^a   Averbuch, Tali ^a   Witkoski, Amy ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adolescent females; Cervical cancer; Human papillomavirus (HPV); Papanicolaou(Pap) tests; Parent adolescent communication; Patient education; Prevention; Sexual risk; Sexually transmitted infection; Vaccines

Indexed keywords

EID: 58849166097     PISSN: 08842175     EISSN: 15526909     Source Type: Journal    
DOI: 10.1111/j.1552-6909.2008.00304.x     Document Type: Article

References (86)

1. Akers, A. Y., Newmann, S. J., & Smith, J. S. (2007). Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Current Problems in Cancer, 31 (3), 157-181.
2. American Academy of Family Physicians. (2007). Policy statement regarding consideration of the mandated use of HPV vaccine for school attendance. Retrieved September 4, 2008, from http://www.aafp.org/online/ en/home/clinical/immunizationres/mandatedhpv.html
3. American Cancer Society. (2008). What are the key statistics about cervical cancer? Retrieved August 26, 2008, from http://www.cancer.org/ docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_cervical_ cancer_8.asp?sitearea
4. American College of Obstetricians and Gynecologists. (2004). Revised cervical cancer screening guidelines require reeducation of women and physicians: All women should have an annual pelvic exam but not all women need annual pap tests. Retrieved September 4, 2008, from http://www.acog.org/from_home/publications/press_releases/ nr05-04-04-1.cfm
5. American College of Obstetricians and Gynecologists. (2007). Revised cervical cancer screening guidelines require reeducation of women and physicians. Retrieved September 4, 2008, from http://www.acog.org/ from_home/publications/press_releases/nr05-04-04-1.cfm
6. American Society for Colposcopy and Cervical Pathology. (2007). Clinical uses of human papillomavirus (HPV) DNA testing. Retrieved September 4, 2008, from http://www.asccp.org/edu/hpv_testing.shtml
7. American Society for Colposcopy and Cervical Pathology. (2008). Practice recommendations: Practice management materials. Retrieved July 16, 2008, from http://www.asccp.org/edu/practice/cervix.shtml#intro
8. Armstrong, L. R., Preston, E. J., Reichert, M., Phillips, D. L., Nisenbaum, R., Todd, N. W., et al. (2000). Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle. Clinical Infectious Diseases, 31 (1), 107-109.
9. Association of Reproductive Health Professionals. (2003). Clinical Proceedings: Advances in cervical cancer prevention. Retrieved July 17, 2008, from http://www.arhp.org/healthcareproviders/cme/onlinecme/hpvcp/ TOC.cfm
10. Beatty, B. G., O'Connell, M., Ashikaga, T., & Cooper, K. (2003). Human papillomavirus (HPV) education in middle and high schools of Vermont. Journal of School Health, 73 (7), 253-257.
11. Bond, S. (2004). New guidelines for Pap screening and management of results. Journal of Midwifery and Women's Health, 49 (1), 57-59.
12. Bosch, F. X., & de Sanjose, S. (2007). The epidemiology of human papillomavirus infection and cervical cancer. Disease Markers, 23 (4), 213-227.
13. Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002). The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology, 55 (4), 244-265.
14. Brewer, N. T., & Fazekas, K. I. (2007). Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Preventive Medicine, 45 (2-3), 107-114.
15. Castellsague, X., Diaz, M., de Sanjose, S., Munoz, N., Herrero, R., Franceschi, S., et al. (2006). Worldwide Human Papillomavirus etiology of cervical adenocarcinoma and its cofactors: Implications for screening and prevention. Journal of the National Cancer Institute, 98 (5), 303-315.
16. Centers for Disease Control. (2006). STD facts: HPV vaccine questions and answers. Retrieved September 4, 2008, from http://www.cdc.gov/std/ hpv/STDFact-HPV-vaccine.htm
17. Centers for Disease Control. (2007a). Cervical cancer: Screening pap test. Retrieved September 4, 2008, from http://www.cdc.gov/cancer/ cervical/basic_info/screening/
18. Centers for Disease Control. (2007b). Human papillomavirus: HPV information for clinicians. Retrieved September 5, 2008, from http://www.cdc.gov/std/Hpv/common-clinicians/ClinicianBro-fp.pdf
19. Centers for Disease Control. (2007c). Summary tables of cervical cancer screening guidelines and recommendations for new technologies. Retrieved September 4, 2008, from http://www.cdc.gov/std/hpv/ScreeningTables.pdf
20. Centers for Disease Control. (2008a). HPV vaccine-Cost effectiveness of HPV vaccine. Retrieved September 3, 2008, from http://www.cdc.gov/ vaccines/vpd-vac/hpv/cost-effect-hpv-vac.htm
21. Centers for Disease Control. (2008b). HPV vaccine information for young women. Retrieved July 16, 2008, from http://www.cdc.gov/std/Hpv/ STDFact-HPV-vaccine.htm
22. Cervarix to receive standard review from FDA. (2007). PharmaWatch: Cancer, 6 (7), 8.
23. Chesson, H. W., Blandford, J. M., Gift, T. L., Tao, G., & Irwin, K. L. (2004). The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspectives on Sexual and Reproductive Health, 36 (1), 11-19.
24. Coker, A. L. (2007). Does physical intimate partner violence affect sexual health? A systematic review. Trauma Violence and Abuse, 8 (2), 149-177.
25. Coughlin, S. S., King, J., Richards, T. B., & Ekwueme, D. U. (2006). Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiology, Biomarkers and Prevention, 15 (11), 2154-2159.
26. Crosby, R. A., & Miller, K. S. (2002). Family influences on adolescent females' sexual health. In G. M. Wingood & R. J. DiClemente (Eds.), Handbook of women's sexual and reproductive health (pp. 113-127). New York: Kluwer Academic Publishers.
27. Daley, A. M., Sadler, L. S., Leventhal, J. M., Cromwell, P. F., & Reynolds, H. D. (2005). Negative pregnancy tests in urban adolescents: An important and often missed opportunity for clinicians. Pediatric Nursing, 31 (2), 87-89.
28. Dempsey, A. F., Zimet, G. D., Davis, R. L., & Koutsky, L. (2006). Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics, 117 (5), 1486-1493.
29. Department of Health and Human Services, Centers for Disease Control and Prevention. (2008a). Vaccines for children program. Retrieved July 16, 2008, from http://www.cdc.gov/vaccines/programs/vfc/default.htm
30. Department of Health and Human Services, Centers for Disease Control and Prevention. (2008b). Gardasil vaccine reports to VAERS. Retrieved July 16, 2008, from http://www.cdc.gov/vaccinesafety/vaers/gardasil.htm
31. DiClemente, R. J., Wingood, G. M., Crosby, R., Cobb, B. K., Harrington, K., & Davies, S. L. (2001). Parent-adolescent communication and sexual risk behaviors among African-American adolescent females. The Journal of Pediatrics, 139 (3), 407-412.
32. Dunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, D. C., Patel, S. S., et al. (2007). Prevalence of HPV infection among females in the United States. Journal of the American Medical Association, 297 (8), 813-819.
33. Eggertson, L. (2007). Adverse events reported for HPV vaccine. Canadian Medical Association Journal, 177 (10), 1169-1170.
34. Friedman, A. L., & Shepeard, H. (2007). Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: Findings from CDC focus group research and implications for practice. Health Education and, 2007; 34 (3), 471-485.
35. Guttmacher Institute. (2006). Facts on sex education in the United States. Retrieved July 16, 2008, from http://www.guttmacher.org/pubs/ fb_sexEd2006.html#21
36. Harris, K. M., Gordon-Larsen, P., Chantala, K., & Udry, J. R. (2006). Longitudinal trends in race/ethnic disparities in leading health indicators from adolescence to young adulthood. Archives of Pediatrics and Adolescent Medicine, 160 (1), 74-81.
37. Henderson, Z., Irwin, K. L., Montano, D. E., Kasprzyk, D., Carlin, L., Greek, A., et al. (2007). Anogenital warts knowledge and counseling practices of US clinicians: Results from a national survey. Sexually Transmitted Diseases, 34 (9), 644-652.
38. Ho, G. Y., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998). Natural history of cervicovaginal papillomavirus infection in young women. New England Journal of Medicine, 338 (7), 423-428.
39. Hogewoning, C. J. A., Bleeker, M. C. G., van den Brule, A. J. C., Voorhorst, F. J., Snijders, P. J. F., Berkhof, J., et al. (2003). Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: A randomized clinical trial. International Journal of Cancer, 107 (5), 811-816
40. Hutchinson, M. K. (2002). The influence of sexual risk communication between parents and daughters on sexual risk behaviors. Family Relations, 51, 238-247.
41. Hutchinson, M. K., Thompson, A. C., & Cederbaum, J. A. (2006). Multisystem factors contributing to disparities in preventive health care among lesbian women. Journal of Obstetric, Gynecologic & Neonatal Nursing, 35 (3), 393-402.
42. International Collaboration of Epidemiological Studies of Cervical Cancer. (2006). Cervical carcinoma and reproductive factors: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. International Journal of Cancer, 119 (5), 1108-1124.
43. Isaacs, B. (2007), January 5. Bill would require that girls be vaccinated against HPV. Lexington Herald-Leader (KY).
44. Kahn, J. A., Lan, D., & Kahn, R. S. (2007). Sociodemographic factors associated with high-risk human papillomavirus infection. [erratum appears in Obstet Gynecol. 2007, 110 (3):713]. Obstetrics and Gynecology, 110 (1), 87-95.
45. Kahn, J. A., Rosenthal, S. L., Tissot, A. M., Bernstein, D. I., Wetzel, C., & Zimet, G. D. (2007). Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambulatory Pediatrics, 7 (5), 367-373.
46. Kim, J. J., & Goldie, S. J. (2008). Health and economic implications of HPV vaccination in the United States. New England Journal of Medicine, 359, 821-832.
47. Koutsky, L. (1997). Epidemiology of genital human papillomavirus infection. American Journal of Medicine, 102 (5A), 3-8.
48. Leyden, W. A., Manos, M. M., Geiger, A. M., Weinmann, S., Mouchawar, J., Bischoff, K., et al. (2005). Cervical cancer in women with comprehensive health care access: Attributable factors in the screening process. Journal of the National Cancer Institute, 97 (9), 675-683
49. Lindström, A. K., Ekman, K., Stendahl, U., Tot, T., Henriksson, R., Hedman, et al. (2008). LRIG1 and squamous epithelial uterine cervical cancer: Correlation to prognosis, other tumor markers, sex steroid hormones, and smoking. International Journal of Gynecological Cancer, 18 (2), 312-317.
50. March of Dimes. (2008). Smoking during pregnancy. Retrieved September 4, 2008, from http://www.marchofdimes.com/professionals/14332_1171.asp
51. Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., Unger, E. R., et al. (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the advisory committee on immunization practices (ACIP). Morbidity and Mortality Weekly Report, Recommendations and Reports, 56 (RR-2), 1-24.
52. Marrazzo, J. M., Koutsky, L. A., Kiviat, N. B., Kuypers, J. M., & Stine, K. (2001). Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. American Journal of Public Health, 91 (6), 947-952.
53. Marshall, H., Philip, R., Don, R., & Peter, B. (2007). A cross-sectional survey to assess community attitudes to introduction of Human Papillomavirus vaccine. Australian and New Zealand Journal of Public Health, 31 (3), 235-242.
54. Merck & Company Incorporated. (2007). Gardasil: The only cervical cancer vaccine. Retrieved July 16, 2008, from http://www.gardasil.com/
55. Middleman, A. B., Rosenthal, S. L., Rickert, V. I., Neinstein, L., Fishbein, D. B., D'Angelo, L., et al. (2006). Adolescent immunizations: A position paper of the society for adolescent medicine. Journal of Adolescent Health, 38 (3), 321-327.
56. Munoz, N., Bosch, F. X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K. V., et al. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine, 348 (6), 518-527.
57. National Association of Nurse Practitioners in Women's Health. (2007). NPWH: Guidelines for cervical cancer screening. Retrieved September 4, 2008, from http://www.npwh.org/files/public/ NPWHCervicalCancerScreeningGuidelinesV2.pdf
58. Newell, R., & Gournay, K. (2000). Mental health nursing: An evidence-based approach. London: Churchill Livingstone.
59. Nielson, C. M., Harris, R. B., Dunne, E. F., Abrahamsen, M., Papenfuss, M. R., Flores, R., et al. (2007). Risk factors for anogenital human papillomavirus infection in men. Journal of Infectious Diseases, 196 (8), 1137-1145
60. Oh, J. K., Ju, Y. H., Franceschi, S., Quint, W., & Shin, H. R. (2008). Acquisition of new infection and clearance of type-specific human papillomavirus infections in female students in Busan, South Korea: A follow-up study [Electronic version]. BMC Infection Diseases, 8 (13). Retrieved July 18, 2008, from http://www.biomedcentral.com/content/ pdf/1471-2334-8-13.pdf
61. Omer, S. B., Pan, W. K. Y., Halsey, N. A., Stokley, S., Moulton, L. H., Navar, A. M., et al. (2006). Nonmedical exemptions to school immunization requirements: Secular trends and association of state policies with pertussis incidence. Journal of the American Medical Association, 296 (14), 1757-1763.
62. Partridge, J. M., Hughes, J. P., Feng, Q., Winer, R. L., Weaver, B. A., Xi, L.-F., et al. (2007). Genital human papillomavirus infection in men: Incidence and risk factors in a cohort of university students [see comment]. Journal of Infectious Diseases, 196 (8), 1128-1136.
63. Petrou, S. (2003). Economic consequences of preterm birth and low birthweight. BJOG: An International Journal of Obstetrics and Gynecology, 110 (Suppl. 20), 17-23.
64. Pollack, A. E., Balkin, M., Edouard, L., Cutts, F., & Broutet, N. (2007). Ensuring access to HPV vaccines through integrated services: A reproductive health perspective. Bulletin of the World Health Organization, 85 (1), 57-63.
65. Revzina, N. V., & Diclemente, R. J. (2005). Prevalence and incidence of human papillomavirus infection in women in the USA: A systematic review. International Journal of STD and AIDS, 16 (8), 528-537.
66. Rosenthal, E. (2008, August 19). Drug makers' push leads to cancer vaccines' rise. The New York Times. Retrieved September 5, 2008, from http://www.nytimes.com
67. Sadler, L. S., Chen, J. Y., Daley, A. M., Leventhal, J. M., & Reynolds, H. (2006). Reproductive care and rates of pregnancy in teenagers with negative pregnancy test results. Journal of Adolescent Health, 38 (3), 222-229.
68. Saslow, D., Runowicz, C. D., Solomon, D., Moscicki, A.-B., Smith, R. A., Eyre, H. J., et al. (2002). American cancer society guideline for the early detection of cervical neoplasia and cancer. CA: A Cancer Journal for Clinicians, 52 (6), 342-362.
69. Sellors, J. W., Karwalajtys, T. L., Kaczorowski, J., Mahony, J. B., Lytwyn, A., Chong, S., et al. (2003). Incidence, clearance and predictors of human papillomavirus infection in women. [see comment]. CMAJ Canadian Medical Association Journal, 168 (4), 421-425.
70. Silins, I., Ryd, W., Strand, A., Wadell, G., Tornberg, S., Hansson, B. G., et al. (2005). Chlamydia trachomatis infection and persistence of human papillomavirus. International Journal of Cancer, 116 (1), 110-115.
71. Singh, G. K., Miller, B. A., Hankey, B. F., & Edwards, B. K. (2004). Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer, 101 (5), 1051-1057.
72. Smith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., et al. (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. International Journal of Cancer, 121 (3), 621-632.
73. Stringer, M., Ratcliffe, S. J., & Gross, R. (2006). Acceptance of hepatitis B vaccination by pregnant adolescents. MCN: The American Journal of Maternal/Child Nursing, 31 (1), 54-60.
74. Sun, X. W., Kuhn, L., Ellerbrock, T. V., Chiasson, M. A., Bush, T. J., & Wright Jr., T. C. (1997). Human papillomavirus infection in women infected with the human immunodeficiency virus. [see comment]. New England Journal of Medicine, 337 (19), 1343-1349.
75. Sussman, A. L., Helitzer, D., Sanders, M., Urquieta, B., Salvador, M., & Ndiaye, K. (2007). HPV and cervical cancer prevention counseling with younger adolescents: Implications for primary care. Annals of Family Medicine, 5 (4), 298-304.
76. Teitelman, A. M., Ratcliffe, S. J., & Cederbaum, J. A. (2008). Parent-adolescent communication about sexual pressure, maternal gender norms about relationship power and HIV protective behaviors of minority urban girls. Journal of the American Psychiatric Nurses Association, 14, 50-60.
77. Tetlock, J. (2008). Jenny's journey. Retrieved September 4, 2008, from http://jenjensfamily.blogspot.com/
78. Tiro, J. A., Meissner, H. I., Kobrin, S., & Chollette, V. (2007). What do women in the U.S. know about human papillomavirus and cervical cancer? Cancer Epidemiology, Biomarkers and Prevention, 16 (2), 288-294.
79. U.S. Cancer Statistics Working Group. (2007). United States cancer statistics: 2004 incidence and mortality. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute.
80. U.S. Food and Drug Administration. (2008). FDA approves expanded uses for Gardasil to include preventing certain vulvar and vaginal cancers. Retrieved September 18, 2008, from http://www.fda.gov/bbs/topics/NEWS/ 2008/NEW01885.html
81. U.S. Preventive Services Task Force. (2003). Screening for cervical cancer: Recommendations and rationale. American Journal of Nursing, 103 (11), 101-102.
82. Weinstock, H., Berman, S., & Cates Jr., W. (2004). Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspectives on Sexual and Reproductive Health, 36 (1), 6-10.
83. Whitaker, D. J., Miller, K. S., May, D. C., & Levin, M. L. (1999). Teenage partners' communication about sexual risk and condom use: The importance of parent-teenager discussions. Family Planning Perspectives, 31 (3), 117-121.
84. Wiley, D. J., Douglas, J., Beutner, K., Cox, T., Fife, K., Moscicki, A.-B., et al. (2002). External genital warts: Diagnosis, treatment, and prevention. Clinical Infectious Diseases, 35 (Suppl. 2), S210-S224.
85. Winer, R. L., Lee, S.-K., Hughes, J. P., Adam, D. E., Kiviat, N. B., & Koutsky, L. A. (2003). Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. [see comment] [erratum appears in Am J Epidemiol. 2003157(9):858]. American Journal of Epidemiology, 157 (3), 218-226.
86. Wright Jr., T. C., Cox, J. T., Massad, L. S., Twiggs, L. B., Wilkinson, E. J., & Conference, A. S.-S. C. (2002). 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. Journal of the American Medical Association, 287 (16), 2120-2129.